Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor B and ets prevents abdominal aortic aneurysm in rat model

Molecular Therapy

Volumn 19, Issue 1, 2011, Pages 181-187

  Miyake, Takashi ^a   Aoki, Motokuni ^a,b   Osako, Mariana K ^a   Shimamura, Munehisa ^a   Nakagami, Hironori ^a   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b MORINOMIYA UNIVERSITY OF MEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; CATHEPSIN B; CATHEPSIN K; ELASTASE; ENDONUCLEASE; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE ELASTASE; OLIGODEOXYNUCLEOTIDE; PHOSPHOROTHIOIC ACID; PROTEINASE; RIBBON TYPE DECOY OLIGODEOXYNUCLEOTIDE; TRANSCRIPTION FACTOR ETS; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA WALL; ARTERY DILATATION; ARTICLE; CHIMERA; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG LABELING; DRUG MECHANISM; DRUG TREATMENT FAILURE; ELASTIC FIBER; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME RELEASE; MACROPHAGE MIGRATION; MALE; NONHUMAN; PROTEIN FUNCTION; RAT;

RATTUS;

EID: 85027929370     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.208     Document Type: Article

References (15)

1. The UK Small Aneurysm Trial Participants. (1998). Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 352: 1649-1655.
2. Lederle, FA, Wilson, SE, Johnson, GR, Reinke, DB, Littooy, FN, Acher, CW et al. (2002). Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 346: 1437-1444.
3. Shah, PK (1997). Infammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm. Circulation 96: 2115-2117.
4. Bond, M, Baker, AH and Newby, AC (1999). Nuclear factor KB activity is essential for matrix metalloproteinase-1 and -3 upregulation in rabbit dermal fbroblasts. Biochem Biophys Res Commun 264: 561-567.
5. Takeshita, H, Yoshizaki, T, Miller, WE, Sato, H, Furukawa, M, Pagano, JS et al. (1999). Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. J Virol 73: 5548-5555.
6. Kim, H and Koh, G (2000). Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-KB-dependent pathway. Biochem Biophys Res Commun 269: 401-405.
7. Kuang, PP, Berk, JL, Rishikof, DC, Foster, JA, Humphries, DE, Ricupero, DA et al. (2002). NF-KB induced by IL-1p inhibits elastin transcription and myofbroblast phenotype. Am J Physiol, Cell Physiol 283: C58-C65.
8. Kouba, DJ, Chung, KY, Nishiyama, T, Vindevoghel, L, Kon, A, Klement, JF et al. (1999). Nuclear factor-K B mediates TNF-cc inhibitory effect on a 2(I) collagen (COL1A2) gene transcription in human dermal fbroblasts. J Immunol 162: 4226-4234.
9. Vandenbunder, B, Wernert, N, Queva, C, Desbiens, X and Stehelin, D (1994). Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion? Folia Biol (Praha) 40: 301-313. (Pubitemid 24359939)
10. Gum, R, Lengyel, E, Juarez, J, Chen, JH, Sato, H, Seiki, M et al. (1996). Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J Biol Chem 271: 10672-10680.
11. Watabe, T, Yoshida, K, Shindoh, M, Kaya, M, Fujikawa, K, Sato, H et al. (1998). The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int J Cancer 77: 128-137.
12. Nakashima, H, Aoki, M, Miyake, T, Kawasaki, T, Iwai, M, Jo, N et al. (2004). Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor KB and ets transcription factors. Circulation 109: 132-138.
13. Miyake, T, Aoki, M, Masaki, H, Kawasaki, T, Oishi, M, Kataoka, K et al. (2007). Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor KB and ets in a rabbit model. Circ Res 101: 1175-1184.
14. Morishita, R, Higaki, J, Tomita, N and Ogihara, T (1998). Application of transcription factor "decoy" strategy as means of gene therapy and study of gene expression in cardiovascular disease. Circ Res 82: 1023-1028.
15. Eder, PS, DeVine, RJ, Dagle, JM and Walder, JA (1991). Substrate specifcity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma. Antisense Res Dev 1: 141-151.